Skip to main content
Top
Published in: Globalization and Health 1/2014

Open Access 01-12-2014 | Research

Local production of pharmaceuticals in Africa and access to essential medicines: 'urban bias’ in access to imported medicines in Tanzania and its policy implications

Authors: Phares GM Mujinja, Maureen Mackintosh, Mary Justin-Temu, Marc Wuyts

Published in: Globalization and Health | Issue 1/2014

Login to get access

Abstract

Background

International policy towards access to essential medicines in Africa has focused until recently on international procurement of large volumes of medicines, mainly from Indian manufacturers, and their import and distribution. This emphasis is now being challenged by renewed policy interest in the potential benefits of local pharmaceutical production and supply. However, there is a shortage of evidence on the role of locally produced medicines in African markets, and on potential benefits of local production for access to medicines. This article contributes to filling that gap.

Methods

This article uses WHO/HAI data from Tanzania for 2006 and 2009 on prices and sources of a set of tracer essential medicines. It employs innovative graphical methods of analysis alongside conventional statistical testing.

Results

Medicines produced in Tanzania were equally likely to be found in rural and in urban areas. Imported medicines, especially those imported from countries other than Kenya (mainly from India) displayed 'urban bias’: that is, they were significantly more likely to be available in urban than in rural areas. This finding holds across the range of sample medicines studied, and cannot be explained by price differences alone. While different private distribution networks for essential medicines may provide part of the explanation, this cannot explain why the urban bias in availability of imported medicines is also found in the public sector.

Conclusions

The findings suggest that enhanced local production may improve rural access to medicines. The potential benefits of local production and scope for their improvement are an important field for further research, and indicate a key policy area in which economic development and health care objectives may reinforce each other.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wexler A, Valentine A, Kates J: Donor funding for health in low- and middle-income countries 2002-2010. 2010, Menlo Park Ca: Kaiser Family Foundation Wexler A, Valentine A, Kates J: Donor funding for health in low- and middle-income countries 2002-2010. 2010, Menlo Park Ca: Kaiser Family Foundation
2.
go back to reference The Global Fund: Making a Difference: Sub-Saharan Africa. 2011, Geneva: The Global Fund The Global Fund: Making a Difference: Sub-Saharan Africa. 2011, Geneva: The Global Fund
3.
go back to reference Ravishankar N, Gubbins P, Cooley JC, Leach-Kemon K, Michaud CM, Jamison DT, Murray CJL: Financing of global health: tracking development assistance for health from 1990 to 2007. Lancet. 2009, 373: 2113-2124. 10.1016/S0140-6736(09)60881-3.PubMedCrossRef Ravishankar N, Gubbins P, Cooley JC, Leach-Kemon K, Michaud CM, Jamison DT, Murray CJL: Financing of global health: tracking development assistance for health from 1990 to 2007. Lancet. 2009, 373: 2113-2124. 10.1016/S0140-6736(09)60881-3.PubMedCrossRef
4.
go back to reference Murray CJ, Anderson B, Burstein R, Leach-Kemon K, Schneider M, Tardif A, Zhang R: Development assistance for health: trends and prospects. Lancet. 2011, 378: 8-10. 10.1016/S0140-6736(10)62356-2.PubMedCrossRef Murray CJ, Anderson B, Burstein R, Leach-Kemon K, Schneider M, Tardif A, Zhang R: Development assistance for health: trends and prospects. Lancet. 2011, 378: 8-10. 10.1016/S0140-6736(10)62356-2.PubMedCrossRef
5.
go back to reference Chaudhuri S, Mackintosh M, Mujinja PGM: Indian generics producers, access to essential medicines and local production in Africa: an argument with reference to Tanzania. Eur J Dev Res. 2010, 22 (4): 451-468. 10.1057/ejdr.2010.27.CrossRef Chaudhuri S, Mackintosh M, Mujinja PGM: Indian generics producers, access to essential medicines and local production in Africa: an argument with reference to Tanzania. Eur J Dev Res. 2010, 22 (4): 451-468. 10.1057/ejdr.2010.27.CrossRef
6.
go back to reference Shadlen K: The political economy of AIDS treatment: intellectual property and the transformation of generic supply. Int Stud Q. 2007, 51: 559-581. 10.1111/j.1468-2478.2007.00464.x.CrossRef Shadlen K: The political economy of AIDS treatment: intellectual property and the transformation of generic supply. Int Stud Q. 2007, 51: 559-581. 10.1111/j.1468-2478.2007.00464.x.CrossRef
7.
8.
go back to reference Kaplan W, Laing R: Local production of pharmaceuticals: industrial policy and access to medicines: an overview of key concepts, issues and opportunities for future research. Health, nutrition and population discussion paper. 2005, Washington: World Bank, January Kaplan W, Laing R: Local production of pharmaceuticals: industrial policy and access to medicines: an overview of key concepts, issues and opportunities for future research. Health, nutrition and population discussion paper. 2005, Washington: World Bank, January
9.
go back to reference Bate R, Coticelli P, Tren R, Attaran A: Antimalarial drug quality in the most severely malarious parts of Africa – a six country study. PLoS One. 2008, 3 (5): e2132-10.1371/journal.pone.0002132.PubMedPubMedCentralCrossRef Bate R, Coticelli P, Tren R, Attaran A: Antimalarial drug quality in the most severely malarious parts of Africa – a six country study. PLoS One. 2008, 3 (5): e2132-10.1371/journal.pone.0002132.PubMedPubMedCentralCrossRef
10.
go back to reference Kaplan W: Local production and access to medicines in low- and middle-income countries: a literature review and critical analysis. 2011, Geneva: World Health Organization Kaplan W: Local production and access to medicines in low- and middle-income countries: a literature review and critical analysis. 2011, Geneva: World Health Organization
11.
go back to reference Anderson T: The tide turns for drug manufacturing in Africa. Lancet. 2010, 375: 1597-10.1016/S0140-6736(10)60687-3.PubMedCrossRef Anderson T: The tide turns for drug manufacturing in Africa. Lancet. 2010, 375: 1597-10.1016/S0140-6736(10)60687-3.PubMedCrossRef
12.
go back to reference World Health Organization (WHO): World medicines situation. 2011, Geneva: WHO World Health Organization (WHO): World medicines situation. 2011, Geneva: WHO
13.
go back to reference World Health Organization (WHO): Local production for access to medical products: developing a framework to improve public health. 2011, Geneva: WHO World Health Organization (WHO): Local production for access to medical products: developing a framework to improve public health. 2011, Geneva: WHO
16.
go back to reference United Nations Industrial Development Organization (UNIDO)/GTZ: The viability of pharmaceutical manufacturing in Ghana to address priority endemic diseases in the West Africa sub-region. 2007, Vienna: UNIDO United Nations Industrial Development Organization (UNIDO)/GTZ: The viability of pharmaceutical manufacturing in Ghana to address priority endemic diseases in the West Africa sub-region. 2007, Vienna: UNIDO
19.
go back to reference African Union COHRED: NEPAD strengthening pharmaceutical innovation in Africa NEPAD-COHRED. 2010 African Union COHRED: NEPAD strengthening pharmaceutical innovation in Africa NEPAD-COHRED. 2010
20.
go back to reference United Nations Industrial Development Organization (UNIDO): Pharmaceutical sector profile: Uganda. 2010, Vienna: UNIDO United Nations Industrial Development Organization (UNIDO): Pharmaceutical sector profile: Uganda. 2010, Vienna: UNIDO
22.
go back to reference World Health Organization (WHO)/Health Action International: Medicines prices: a new approach to measurement. 2003, Geneva: WHO/HAI World Health Organization (WHO)/Health Action International: Medicines prices: a new approach to measurement. 2003, Geneva: WHO/HAI
23.
go back to reference Ministry of Health and Social Welfare: Standard treatment guidelines and National Essential Medicines List (NEMLIT) for Mainland Tanzania. 2007, Dar es Salaam: United Republic of Tanzania, 3 Ministry of Health and Social Welfare: Standard treatment guidelines and National Essential Medicines List (NEMLIT) for Mainland Tanzania. 2007, Dar es Salaam: United Republic of Tanzania, 3
24.
go back to reference Chambers JM, Cleveland WS, Kleiner B, Tukey PA: Graphical methods for data analysis. 1983, Pacific Grove, California: Wadsworth & Brooks/Cole Publishing, Statistics / Probability Series Chambers JM, Cleveland WS, Kleiner B, Tukey PA: Graphical methods for data analysis. 1983, Pacific Grove, California: Wadsworth & Brooks/Cole Publishing, Statistics / Probability Series
25.
go back to reference Lipton M: Why poor people stay poor: a study of urban bias in world development. 1977, London: Temple Smith Lipton M: Why poor people stay poor: a study of urban bias in world development. 1977, London: Temple Smith
26.
go back to reference Jones GA, Corbridge S: The continuing debate about urban bias: the thesis, its critics, its influence and implications for poverty-reduction strategies. Prog Dev Stud. 2010, 10 (1): 1-18. 10.1177/146499340901000101.CrossRef Jones GA, Corbridge S: The continuing debate about urban bias: the thesis, its critics, its influence and implications for poverty-reduction strategies. Prog Dev Stud. 2010, 10 (1): 1-18. 10.1177/146499340901000101.CrossRef
27.
go back to reference Lipton M: Urban bias: of consequences, classes and causality. J Dev Stud. 1993, 29 (4): 229-258. 10.1080/00220389308422301.CrossRef Lipton M: Urban bias: of consequences, classes and causality. J Dev Stud. 1993, 29 (4): 229-258. 10.1080/00220389308422301.CrossRef
28.
go back to reference Lipton M: Urban bias revisited. J Dev Stud. 1984, 20 (3): 139-166. 10.1080/00220388408421910.CrossRef Lipton M: Urban bias revisited. J Dev Stud. 1984, 20 (3): 139-166. 10.1080/00220388408421910.CrossRef
29.
go back to reference United Republic of Tanzania (URT): Household budget survey 2007. 2009, Dar es Salaam: National Bureau of Statistics United Republic of Tanzania (URT): Household budget survey 2007. 2009, Dar es Salaam: National Bureau of Statistics
30.
go back to reference Kruk ME, Mbaruku G, Rockers PC, Galea S: User fee exemptions are not enough: out-of-pocket payments for 'free’ delivery services in rural Tanzania. Trop Med Int Health. 2008, 13 (12): 1442-1451. 10.1111/j.1365-3156.2008.02173.x.PubMedCrossRef Kruk ME, Mbaruku G, Rockers PC, Galea S: User fee exemptions are not enough: out-of-pocket payments for 'free’ delivery services in rural Tanzania. Trop Med Int Health. 2008, 13 (12): 1442-1451. 10.1111/j.1365-3156.2008.02173.x.PubMedCrossRef
31.
go back to reference Mackintosh M, Tibandebage P: Inclusion by design: rethinking regulatory intervention in Tanzanian health care. J Dev Stud. 2002, 39 (1): 1-20.CrossRef Mackintosh M, Tibandebage P: Inclusion by design: rethinking regulatory intervention in Tanzanian health care. J Dev Stud. 2002, 39 (1): 1-20.CrossRef
32.
go back to reference Tibandebage P, Mackintosh M: The market shaping of charges, trust and abuse: health care transactions in Tanzania. Soc Sci Med. 2005, 61: 1385-1395. 10.1016/j.socscimed.2004.11.072.PubMedCrossRef Tibandebage P, Mackintosh M: The market shaping of charges, trust and abuse: health care transactions in Tanzania. Soc Sci Med. 2005, 61: 1385-1395. 10.1016/j.socscimed.2004.11.072.PubMedCrossRef
33.
go back to reference Mackintosh M, Mujinja PGM: Markets and policy challenges in access to essential medicines for endemic disease. J Afr Econ. 2010, Supp. 3: iii166-iii200. Mackintosh M, Mujinja PGM: Markets and policy challenges in access to essential medicines for endemic disease. J Afr Econ. 2010, Supp. 3: iii166-iii200.
34.
go back to reference Yohana E, Kamuhabwa A, Mujinja P: Availability and affordability of anticancer medicines at the Ocean Road Cancer Institute in Dar es Salaam, Tanzania. East Afr J Public Health. 2011, 8 (1): 52-57.PubMed Yohana E, Kamuhabwa A, Mujinja P: Availability and affordability of anticancer medicines at the Ocean Road Cancer Institute in Dar es Salaam, Tanzania. East Afr J Public Health. 2011, 8 (1): 52-57.PubMed
38.
go back to reference Alba S, Hetzel MW, Goodman C, Dillip A, Liana J, Mshinda H, Lengeler C: Improvements in access to malaria treatment in Tanzania after switch to artemisinin combination therapy and the introduction of accredited drug dispensing outlets - a provider perspective. Malar J. 2010, 9: 164-10.1186/1475-2875-9-164.PubMedPubMedCentralCrossRef Alba S, Hetzel MW, Goodman C, Dillip A, Liana J, Mshinda H, Lengeler C: Improvements in access to malaria treatment in Tanzania after switch to artemisinin combination therapy and the introduction of accredited drug dispensing outlets - a provider perspective. Malar J. 2010, 9: 164-10.1186/1475-2875-9-164.PubMedPubMedCentralCrossRef
39.
go back to reference Cohen JM, Sabot O, Sabot K, Gordon M, Gross I, Bishop D, Odhiambo M, Ipuge Y, Ward L, Mwita A, Goodman C: A pharmacy too far? Equity and spatial distribution of outcomes in the delivery of subsidized artemisinin-based combination therapies through private drug shops. BMC Health Serv Res. 2010, 10 (Suppl 1): S6-10.1186/1472-6963-10-S1-S6.PubMedPubMedCentralCrossRef Cohen JM, Sabot O, Sabot K, Gordon M, Gross I, Bishop D, Odhiambo M, Ipuge Y, Ward L, Mwita A, Goodman C: A pharmacy too far? Equity and spatial distribution of outcomes in the delivery of subsidized artemisinin-based combination therapies through private drug shops. BMC Health Serv Res. 2010, 10 (Suppl 1): S6-10.1186/1472-6963-10-S1-S6.PubMedPubMedCentralCrossRef
40.
go back to reference Galway L, Corbett K, Zeng L: Where are the NGOs and why? The distribution of health and development NGOs in Bolivia. Glob Health. 2011, 8: 38-CrossRef Galway L, Corbett K, Zeng L: Where are the NGOs and why? The distribution of health and development NGOs in Bolivia. Glob Health. 2011, 8: 38-CrossRef
41.
go back to reference Ahmed SM, Hossain MA, Mushtaque A, Chowdhury R, Bhuiya AU: The health workforce crisis in Bangladesh: shortage, inappropriate skill-mix and inequitable distribution. Hum Resour Health. 2011, 9: 3-10.1186/1478-4491-9-3.PubMedPubMedCentralCrossRef Ahmed SM, Hossain MA, Mushtaque A, Chowdhury R, Bhuiya AU: The health workforce crisis in Bangladesh: shortage, inappropriate skill-mix and inequitable distribution. Hum Resour Health. 2011, 9: 3-10.1186/1478-4491-9-3.PubMedPubMedCentralCrossRef
42.
go back to reference Makwiza I, Nyirenda L, Bongololo G, Banda T, Chimzizi R, Theobald S: Who has access to counseling and testing and anti-retroviral therapy in Malawi – an equity analysis. Int J Equity Health. 2009, 8: 13-10.1186/1475-9276-8-13.PubMedPubMedCentralCrossRef Makwiza I, Nyirenda L, Bongololo G, Banda T, Chimzizi R, Theobald S: Who has access to counseling and testing and anti-retroviral therapy in Malawi – an equity analysis. Int J Equity Health. 2009, 8: 13-10.1186/1475-9276-8-13.PubMedPubMedCentralCrossRef
43.
go back to reference Cameron A, Roubos I, Ewen M, Mantel-Teeuwisse AK, Leufkensb HGM, Laing RO: Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries. Bull World Health Organ. 2011, 89: 412-421. 10.2471/BLT.10.084327.PubMedPubMedCentralCrossRef Cameron A, Roubos I, Ewen M, Mantel-Teeuwisse AK, Leufkensb HGM, Laing RO: Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries. Bull World Health Organ. 2011, 89: 412-421. 10.2471/BLT.10.084327.PubMedPubMedCentralCrossRef
44.
go back to reference Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R: Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet. 2008, 373: 240-49PubMedCrossRef Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R: Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet. 2008, 373: 240-49PubMedCrossRef
45.
go back to reference Yadav P, Cohen JL, Alphs S, Arkedis J, Larson PS, Massaga J, Sabo O: Trends in availability and prices of subsidized ACT over the first year of the AMFm: evidence from remote regions of Tanzania. Malar J. 2012, 11: 299-10.1186/1475-2875-11-299.PubMedPubMedCentralCrossRef Yadav P, Cohen JL, Alphs S, Arkedis J, Larson PS, Massaga J, Sabo O: Trends in availability and prices of subsidized ACT over the first year of the AMFm: evidence from remote regions of Tanzania. Malar J. 2012, 11: 299-10.1186/1475-2875-11-299.PubMedPubMedCentralCrossRef
46.
go back to reference Ministry of Health and Social Welfare with Ifakara Health Institute: Midterm analytical review of the health sector strategic plan 2009-2015. 2013, Dar es Salaam: Ministry of Health and Social Welfare Ministry of Health and Social Welfare with Ifakara Health Institute: Midterm analytical review of the health sector strategic plan 2009-2015. 2013, Dar es Salaam: Ministry of Health and Social Welfare
Metadata
Title
Local production of pharmaceuticals in Africa and access to essential medicines: 'urban bias’ in access to imported medicines in Tanzania and its policy implications
Authors
Phares GM Mujinja
Maureen Mackintosh
Mary Justin-Temu
Marc Wuyts
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Globalization and Health / Issue 1/2014
Electronic ISSN: 1744-8603
DOI
https://doi.org/10.1186/1744-8603-10-12

Other articles of this Issue 1/2014

Globalization and Health 1/2014 Go to the issue